Anti-nucleocapsid SARS-CoV-2 antibody seroprevalence in previously infected persons with immunocompromising conditions—United States, 2020–2022

Anti-nucleocapsid SARS-CoV-2 antibody seroprevalence in previously infected persons with immunocompromising conditions—United States, 2020–2022

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	Anna Bratcher, Jefferson M. Jones, William A. Meyer, Rehan Waheed, Huda Yazgi, Aaron Harris, Adi V. Gundlapalli, Kristie E. N. Clarke
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11709286/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Anti-nucleocapsid SARS-CoV-2 antibody seroprevalence in previously infected persons with immunocompromising conditions-United States, 2020-2022.
by: Anna Bratcher, et al.
Published: (2025-01-01)

Induction of Humoral and Cellular Immunity by Intradermal Delivery of SARS-CoV-2 Nucleocapsid Protein Using Dissolvable Microneedles
by: Chaiyaporn Kuwentrai, et al.
Published: (2021-01-01)

Identification of G-quadruplex-forming Sequences in Nucleocapsid Gene of SARS-CoV-2 Variants of Concern: An In Silico Analysis
by: Saeedeh Ghazaey Zidanloo
Published: (2024-02-01)

Comparative evaluation of cell-based assay technologies for scoring drug-induced condensation of SARS-CoV-2 nucleocapsid protein
by: Rui Tong Quek, et al.
Published: (2025-03-01)

Reply to “Vaccination caused underestimation of cumulative incidence of SARS-CoV-2 infection”
by: Jefferson M. Jones, et al.
Published: (2025-02-01)

High prevalence of undocumented SARS-CoV-2 infections revealed by analysis of nucleocapsid-specific IgG responses in diagnosed and undiagnosed individuals.
by: Kim Blom, et al.
Published: (2025-01-01)

Seroprevalence of SARS-CoV-2 Infection Among People Living with HIV in Libreville, Gabon
by: Samira Zoa-Assoumou, et al.
Published: (2024-12-01)

Adaptive evolution of SARS-CoV-2 during a persistent infection for 521 days in an immunocompromised patient
by: Hanno Schmidt, et al.
Published: (2025-01-01)

The R203M and D377Y mutations of the nucleocapsid protein promote SARS-CoV-2 infectivity by impairing RIG-I-mediated antiviral signaling.
by: Yongkui Li, et al.
Published: (2025-01-01)

Seroprevalence against SARS-CoV-2 after booster vaccination in a prison in Alicante (Spain)
by: Ana C. Montagud, et al.
Published: (2025-01-01)

The omicron variant of SARS-CoV-2 drove broadly increased seroprevalence in a public university setting.
by: Ching-Wen Hou, et al.
Published: (2025-01-01)

Seroprevalence of IgM/IgG and Neutralizing Antibodies against SARS-CoV-2 in Unvaccinated Young Adults from Mexico Who Reported Not Having Had a Previous COVID-19 Infection
by: Diana Lourdes Padilla-Bórquez, et al.
Published: (2024-01-01)

Seroprevalence of SARS-CoV-2 and risk factors for infection among children in Uganda: A serial cross-sectional study.
by: Irene Bagala, et al.
Published: (2024-01-01)

Asymptomatic lung abscess of aspergillus in a female without previous lung diseases or immunocompromise: a case report
by: Hanxue Xiang, et al.
Published: (2025-01-01)

Seroprevalence of SARS-CoV-2 virus antibodies and sociodemographic features of pregnant women in Mogadishu, Somalia: a cross-sectional survey study
by: Maryan Abdullahi Sh. Nur, et al.
Published: (2022-06-01)

Critical Care Management for Novel 2019 SARS-CoV-2 and HCoV-NL63 Coinfection in a Young Immunocompromised Patient: A Chicago Experience
by: Alejandro Sanchez-Nadales, et al.
Published: (2020-01-01)

Correction: Seroprevalence of SARS-CoV-2 virus antibodies and sociodemographic features of pregnant women in Mogadishu, Somalia: a cross-sectional survey study
Published: (2022-06-01)

Computational analysis of SARS-CoV-2, SARS-CoV, and MERS-CoV genome using MEGA
by: Vipan Kumar Sohpal
Published: (2020-09-01)

Unravelling the impact of SARS-CoV-2 on hemostatic and complement systems: a systems immunology perspective
by: Didar Murad, et al.
Published: (2025-01-01)

SARS-CoV-2 infection and antibody seroprevalence in routine surveillance patients, healthcare workers and general population in Kita region, Mali: an observational study 2020–2021
by: Ulla Ashorn, et al.
Published: (2022-06-01)

MODES OF SARS-COV-2 TRANSMISSION
by: Nilesh D. Patel, et al.
Published: (2021-07-01)

Lessons from SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections: What We Know So Far
by: Radi Taha Alsafi
Published: (2022-01-01)

Airborne Transmission of the SARS-CoV-2 Delta Variant and the SARS-CoV-2 Omicron Variant
by: Byung Uk Lee
Published: (2021-12-01)

Co-Occurrence of SARS-CoV-2 Infection and Inactivated SARS-CoV-2 Vaccination among Healthcare Workers
by: Cucunawangsih Cucunawangsih, et al.
Published: (2021-01-01)

TRIM8 inhibits porcine epidemic diarrhoea virus replication by targeting and ubiquitinately degrading the nucleocapsid protein
by: Zhenbin Bi, et al.
Published: (2025-01-01)

Pulmonary Talcosis in an Immunocompromised Patient
by: Thanh-Phuong Nguyen, et al.
Published: (2016-01-01)

Pneumonia Severity Index in the Immunocompromised
by: Kevin M Sanders, et al.
Published: (2006-01-01)

CMV Pancreatitis in an Immunocompromised Patient
by: Jaffer Ahmad, et al.
Published: (2021-01-01)

Bullous Scabies in an Immunocompromised Host
by: James R. Wester, et al.
Published: (2022-01-01)

Diagnosis of Cellulitis in the Immunocompromised Host
by: Charles F Carey, et al.
Published: (1990-01-01)

Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster dosesResearch in context
by: Annalisa Ciabattini, et al.
Published: (2025-03-01)

Enfisema subcutáneo y neumomediastino en un paciente con infección por SARS-COV-2: SEPIM-SARS-COV-2
by: Jesica Naanous-Rayek, et al.
Published: (2024-01-01)

Myocardial Damage in SARS-CoV-2 Infection
by: Elizabeth Sellén Sanchén, et al.
Published: (2020-11-01)

Clinical Traits of SARS-CoV-2 Infection
by: O. Yu. Zolnikova, et al.
Published: (2020-12-01)

Bat reservoirs related to SARS-CoV-2
by: Sebastian Iglesias
Published: (2020-09-01)

Aspergillus Thyroiditis: A Complication of Respiratory Tract Infection in an Immunocompromised Patient
by: Madiha M. Alvi, et al.
Published: (2013-01-01)

Necrotizing Fasciitis in an Immunocompromised Elderly Woman
by: Ananda Ghosh, et al.
Published: (2013-01-01)

Pasteurella multocida Bacteremia in an Immunocompromised Patient
by: Shweta Kukrety, et al.
Published: (2016-01-01)

SARS-CoV-2 drug resistance and therapeutic approaches
by: Sania Batool, et al.
Published: (2025-01-01)

On the space of SARS-CoV-2 genetic sequence variants
by: A. Yu. Palyanov, et al.
Published: (2023-12-01)